Advancing a clinical drug targeting the complement system to treat COVID-19 (2021-2022)
Abstract
COVID-19 is an infectious and potentially lethal respiratory disease that has altered the way we all live. There is, therefore, an urgent need to identify effective drugs for this disease. This project entails validating and advancing a pre-existing clinical drug that targets our immune system, in the hope of finding an effective therapy for COVID-19 patients.
